Clinical Trials Directory

Trials / Completed

CompletedNCT06338761

Switching to E-cigarette After PCI

Prognostic Impact of Switching to E-Cigarette Use in Smokers With Coronary Artery Disease Following Percutaneous Coronary Intervention: A Nationwide Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
17,973 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI) remains uncertain.

Detailed description

Recently, several studies have reported that, although lower than combustible cigarette users, E-cigarette users had a significantly higher risk of future myocardial infarction (MI) or cardiovascular disease compared with non-smokers or quitters. However, because all previous studies has focused on the general healthy population, these results cannot be extrapolated for patients who already proven atherosclerotic cardiovascular disease (ASCVD), such as undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Although Busch et al. previously reported that a significant minority of patients are using E-cigarettes post-acute coronary syndrome smokers, a paucity of data exists regarding the impact of such transitions on clinical outcomes in current smoker patients with CAD who have undergone PCI. In light of these considerations, the current study sought to address this gap in knowledge by evaluating the prognostic implications of smoking habit changes, including E-cigarette use, among CAD patients with current smoking status following PCI.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSmoking cessationStop smoking
BEHAVIORALSwitching to E-cigaretteSwitching to E-cigarette

Timeline

Start date
2024-01-01
Primary completion
2024-12-31
Completion
2025-03-15
First posted
2024-04-01
Last updated
2025-05-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06338761. Inclusion in this directory is not an endorsement.